Solid Biosciences (SLDB) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[4], including 1 Phase 3[1], 2 Phase 2[2], 4 Phase 1[3].
Trial NCT07160634[5] evaluates SGT-003 in Duchenne Muscular Dystrophy with a target enrollment of 80 participants.
SLDB has 1 Form 4 insider filing recorded at the SEC in the past 30 days[6].